Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrphostins: Potent inhibitors of EGF receptor tyrosine kinase in vitro

Journal of Medicinal Chemistry

Volumn 39, Issue 25, 1996, Pages 4905-4911

  Gazit, Aviv ^a   Osherov, Nir ^a   Gilon, Chaim ^a   Levitzki, Alexander ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLIDENE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; MALONONITRILE; ONCOPROTEIN; TYRPHOSTIN;

ARTICLE; AUTOPHOSPHORYLATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INACTIVATION; ENZYME SUBSTRATE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

BENZYLIDENE COMPOUNDS; ENZYME INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029753803     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960225d     Document Type: Article

References (14)

1. Bishop, J. M. The molecular genetic of cancer. Science 1987, 335, 305-3118.
2. Ullrich, A.; Shlesainger, J. Signal transduction genetics of cancer by receptors with tyrosine kinase activity. Cell 1990, 61, 203-212.
3. Levitzki, A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J. 1992, 6, 3275-3282.
4. Osherov, N.; Levitzki, A. Epidermal growth factor dependent activation of Src family kinases. Eur. J. Biochem. 1994, 225, 1047-1053.
5. Levitzki, A.; Gazit, A. Tyrosine kinases inhibition:An Approach to Drug Development, Science 1995, 267, 1782-1788.
6. Levitzki, A. Targeting signal transduction for disease therapy. Current Opin. Cell. Biol. 1996, 8, 239-244.
7. Portoghese, P. S.; Nogases, J.; Lipkowski, A. W.; Larson, D. L.; Takemari, A. E. Binaltorphimine related bivalent ligands and their κ opioid receptor antagonist selectivity. J. Med. Chem. 1988, 31, 836-841.
8. Gazit, A.; Yaish, P.; Gilon, C.; Levitzki, A. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 1989, 32, 2344-2352.
9. Gazit, A.; Osherov, N.; Posner, I.; Yaish, P.; Poradosu, E.; Gilon, C.; Levitzki, A. Tyrphostins II: Heterocyclic and α-substituted Benzenemalononitrile Tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu Tyrosine kinases. J. Med. Chem. 1991, 34, 1896-1907.
10. Gazit, A.; Osherov, N.; Posner, I.; Bar-Sinai, A.; Gilon, C.; Levitzki, A. Tyrphostins III: Structure-activity relationship studies of α-substituted benzylidene malononitrile 5-S-aryl tyrphostins. J. Med. Chem. 1993, 36, 3556-3564.
11. Osherov, N.; Gazit, A.; Gilon, C.; Levitzki, A. Selective inhibition of the epidermal growth factor and HER2/neu receptors by Tyrphostins. J. Biol. Chem. 1993, 268, 11134-11142.
12. Posner, I.; Engel, M.; Gazit, A.; Levitzki, A. Kinetics of inhibition of the tyrosine kinase activity of the epidermal growth factor receptor by tyrphostins. Mol. Pharmacol. 1993, 45, 673-683.
13. Perez, R. A.; Alvarez, E. F.; Nieto, O.; Piedrafita, F. J. Dihydroxy nitrobenzaldehydes. Synthesis and biological activity as catechol O-methyl transferase inhibitors. J. Med. Chem. 1992, 35, 4584-4588.
14. Levitzki, A.; Gazit, A.; Osherov, N.; Posner, I.; Gilon, C. Inhibition of Protein-Tyrosine kinases by Tyrphostins. Methods Enzymol. 1991, 201, 347-361.